MA49395A - Polynucléotides codant pour le facteur viii de coagulation - Google Patents

Polynucléotides codant pour le facteur viii de coagulation

Info

Publication number
MA49395A
MA49395A MA049395A MA49395A MA49395A MA 49395 A MA49395 A MA 49395A MA 049395 A MA049395 A MA 049395A MA 49395 A MA49395 A MA 49395A MA 49395 A MA49395 A MA 49395A
Authority
MA
Morocco
Prior art keywords
polynucleotides
factor viii
coagulation factor
viii coding
coding
Prior art date
Application number
MA049395A
Other languages
English (en)
Inventor
Paolo Martini
Carol H Miao
Raj Rajendran
Original Assignee
Modernatx Inc
Seattle Childrens Hospital D/B/A Seattle Childrens Res Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Modernatx Inc, Seattle Childrens Hospital D/B/A Seattle Childrens Res Institute filed Critical Modernatx Inc
Publication of MA49395A publication Critical patent/MA49395A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/37Factors VIII
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA049395A 2017-06-14 2018-06-13 Polynucléotides codant pour le facteur viii de coagulation MA49395A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762519827P 2017-06-14 2017-06-14
US201762589914P 2017-11-22 2017-11-22
US201862663839P 2018-04-27 2018-04-27

Publications (1)

Publication Number Publication Date
MA49395A true MA49395A (fr) 2020-04-22

Family

ID=63013083

Family Applications (1)

Application Number Title Priority Date Filing Date
MA049395A MA49395A (fr) 2017-06-14 2018-06-13 Polynucléotides codant pour le facteur viii de coagulation

Country Status (4)

Country Link
US (1) US20200268666A1 (fr)
EP (1) EP3638292A1 (fr)
MA (1) MA49395A (fr)
WO (1) WO2018232006A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240279649A1 (en) * 2021-05-11 2024-08-22 Seattle Children's Hospital D/B/A Seattle Children's Research Institute Gene editing for expression of functional factor viii for the treatment of hemophilia
CN115745819A (zh) * 2021-09-03 2023-03-07 广州谷森制药有限公司 新型阳离子脂质化合物
NL2030022B1 (en) * 2021-12-03 2023-06-21 Wisdom Pharmaceutical Co Ltd SYNTHESIS OF mRNA TRANSMITTER

Family Cites Families (145)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8613481D0 (en) 1986-06-04 1986-07-09 Diatech Ltd Translation of mrna
US5563250A (en) 1987-12-02 1996-10-08 Neorx Corporation Cleavable conjugates for the delivery and release of agents in native form
US5505931A (en) 1993-03-04 1996-04-09 The Dow Chemical Company Acid cleavable compounds, their preparation and use as bifunctional acid-labile crosslinking agents
EP0730645A1 (fr) 1993-11-26 1996-09-11 Btg International Limited Adn ameliorant la traduction
US5681702A (en) 1994-08-30 1997-10-28 Chiron Corporation Reduction of nonspecific hybridization by using novel base-pairing schemes
US5795587A (en) 1995-01-23 1998-08-18 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
US5824497A (en) 1995-02-10 1998-10-20 Mcmaster University High efficiency translation of mRNA molecules
US6265389B1 (en) 1995-08-31 2001-07-24 Alkermes Controlled Therapeutics, Inc. Microencapsulation and sustained release of oligonucleotides
US20030073640A1 (en) 1997-07-23 2003-04-17 Ribozyme Pharmaceuticals, Inc. Novel compositions for the delivery of negatively charged molecules
US6004573A (en) 1997-10-03 1999-12-21 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US6517869B1 (en) 1997-12-12 2003-02-11 Expression Genetics, Inc. Positively charged poly(alpha-(omega-aminoalkyl)lycolic acid) for the delivery of a bioactive agent via tissue and cellular uptake
ZA9811377B (en) 1997-12-12 1999-08-27 Expression Genetics Inc Positively charged poly[alpha-(omega-aminoalkyl) glycolic acid[ for the delivery of a bioactive agent via tissue and cellular uptake.
JP2002500201A (ja) 1998-01-05 2002-01-08 ユニバーシティ オブ ワシントン 膜破壊剤を使用する増強された輸送
US6426086B1 (en) 1998-02-03 2002-07-30 The Regents Of The University Of California pH-sensitive, serum-stable liposomes
TR200003441T2 (tr) 1998-05-20 2001-04-20 Expression Genetics, Inc. Hepatositi hedefleyen polietilen gliko-ekli poli-l-lisin polimerik bir gen taşıyıcı
US7091192B1 (en) 1998-07-01 2006-08-15 California Institute Of Technology Linear cyclodextrin copolymers
CN1313873A (zh) 1998-07-13 2001-09-19 表达遗传学公司 作为可溶性,生物可降解基因送递载体的聚-l-赖氨酸的聚酯类似物
US7098032B2 (en) 2001-01-02 2006-08-29 Mirus Bio Corporation Compositions and methods for drug delivery using pH sensitive molecules
EP1102785B1 (fr) 1999-06-07 2013-02-13 Arrowhead Research Corporation Compositions de diffusion de medicaments au moyen de molecules sensibles au ph
WO2001051092A2 (fr) 2000-01-07 2001-07-19 University Of Washington Transport ameliore d'agents au moyen d'agents perturbateurs de membranes
US20040142474A1 (en) 2000-09-14 2004-07-22 Expression Genetics, Inc. Novel cationic lipopolymer as a biocompatible gene delivery agent
US6696038B1 (en) 2000-09-14 2004-02-24 Expression Genetics, Inc. Cationic lipopolymer as biocompatible gene delivery agent
US6897196B1 (en) 2001-02-07 2005-05-24 The Regents Of The University Of California pH sensitive lipids based on ortho ester linkers, composition and method
US6652886B2 (en) 2001-02-16 2003-11-25 Expression Genetics Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
US6586524B2 (en) 2001-07-19 2003-07-01 Expression Genetics, Inc. Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier
EP1412065A2 (fr) 2001-07-27 2004-04-28 President And Fellows Of Harvard College Appareil et procedes de melange de flux laminaires
US20050222064A1 (en) 2002-02-20 2005-10-06 Sirna Therapeutics, Inc. Polycationic compositions for cellular delivery of polynucleotides
WO2003092665A2 (fr) 2002-05-02 2003-11-13 Massachusetts Eye And Ear Infirmary Systemes oculaires de distribution de medicament et utilisation associee
US7883720B2 (en) 2003-07-09 2011-02-08 Wisconsin Alumni Research Foundation Charge-dynamic polymers and delivery of anionic compounds
US8034619B2 (en) 2003-12-19 2011-10-11 University Of Cincinnati Polyamides for nucleic acid delivery
WO2006097793A2 (fr) 2004-04-15 2006-09-21 Chiasma, Ltd. Compositions capables de faciliter la penetration a travers une barriere biologique
US8057821B2 (en) 2004-11-03 2011-11-15 Egen, Inc. Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof
ES2407979T3 (es) 2004-12-10 2013-06-17 Kala Pharmaceuticals, Inc. Copolímeros de bloques de poli(éter-anhídrido) funcionalizados
US7404969B2 (en) 2005-02-14 2008-07-29 Sirna Therapeutics, Inc. Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
WO2007086881A2 (fr) 2005-02-14 2007-08-02 Sirna Therapeutics, Inc. Compositions à base de nanoparticules lipidiques et méthodes pour l'administration de molécules biologiquement actives
EP1885403B1 (fr) 2005-04-12 2013-05-08 Nektar Therapeutics Conjugués de la lysostaphine et du poly(éthylène glycol)
US8101385B2 (en) 2005-06-30 2012-01-24 Archemix Corp. Materials and methods for the generation of transcripts comprising modified nucleotides
EP1907590B1 (fr) 2005-06-30 2012-09-19 Archemix LLC Polymerase t7 arn et procedes pour la generation de transcriptions d'acide nucleiques modifiee completement en 2'
LT2578685T (lt) * 2005-08-23 2019-06-10 The Trustees Of The University Of Pennsylvania Rnr, apimančios modifikuotus nukleozidus ir jų panaudojimo būdai
EP2308505A3 (fr) 2005-09-01 2011-11-30 Novartis Vaccines and Diagnostics GmbH Vaccins multiples comprenant le sérogroupe C de Neisseria meningitidis
DE102005046490A1 (de) 2005-09-28 2007-03-29 Johannes-Gutenberg-Universität Mainz Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen
AU2006325030B2 (en) 2005-12-16 2012-07-26 Cellectis Cell penetrating peptide conjugates for delivering nucleic acids into cells
EP1991560B1 (fr) 2006-02-20 2018-04-04 Ewha University-Industry Collaboration Foundation Peptide présentant une activité de pénétration de membrane cellulaire
CN103030801B (zh) 2006-02-21 2015-07-22 尼克塔治疗公司 嵌段可降解聚合物及由其制备的轭合物
MX2009003680A (es) 2006-10-05 2009-07-17 Univ Johns Hopkins Formulaciones orales, parenterales y topicas dispersables en agua para farmacos deficientemente solubles en agua con el uso de nanoparticulas polimericas inteligentes.
WO2008070118A1 (fr) 2006-12-05 2008-06-12 Landec Corporation Administration de médicaments
AU2007339280B2 (en) 2006-12-21 2013-12-05 Stryker Corporation Sustained-release formulations comprising crystals, macromolecular gels, and particulate suspensions of biologic agents
CA2673029C (fr) 2006-12-22 2017-03-28 Archemix Corp. Materiaux et procedes pour la generation de transcrits comprenant des nucleotides modifies
EP2097108B1 (fr) 2006-12-27 2014-02-12 Nektar Therapeutics Conjugués polymère-fraction à activité facteur ix comprenant une liaison dégradable
AU2008219165A1 (en) 2007-02-16 2008-08-28 Merck Sharp & Dohme Corp. Compositions and methods for potentiated activity of biologicaly active molecules
HUE040417T2 (hu) 2007-05-04 2019-03-28 Marina Biotech Inc Aminosavlipidek és alkalmazásuk
EP2205618B1 (fr) 2007-09-26 2016-11-09 Intrexon Corporation Régions non traduites 5' (5'utr) synthétiques, vecteurs d'expression, et procédés pour augmenter l'expression transgénique
EP2644192B1 (fr) 2007-09-28 2017-05-10 Pfizer Inc Ciblage de cellules de cancer utilisant des nanoparticules
JP2011514423A (ja) 2008-03-14 2011-05-06 エーゲン、インコーポレイテッド 生分解性架橋分枝状ポリ(アルキレンイミン)
PL215513B1 (pl) 2008-06-06 2013-12-31 Univ Warszawski Nowe boranofosforanowe analogi dinukleotydów, ich zastosowanie, czasteczka RNA, sposób otrzymywania RNA oraz sposób otrzymywania peptydów lub bialka
WO2010005725A2 (fr) 2008-06-16 2010-01-14 Bind Biosciences, Inc. Nanoparticules polymères thérapeutiques comprenant des alcaloïdes vinca et procédés de fabrication et d’utilisation associés
US8613951B2 (en) 2008-06-16 2013-12-24 Bind Therapeutics, Inc. Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same
JP2011525180A (ja) 2008-06-16 2011-09-15 バインド バイオサイエンシズ インコーポレイテッド 治療的標的化ナノ粒子の製作に用いるためのジブロックコポリマーで官能化された標的薬の製造方法
ES2765240T3 (es) 2008-06-16 2020-06-08 Pfizer Nanopartículas poliméricas cargadas de fármaco y procedimientos de fabricación y uso de las mismas
EP2326331A4 (fr) 2008-08-18 2013-05-15 Merck Sharp & Dohme Nouvelles nanoparticules lipidiques et nouveaux composants pour l'administration d'acides nucléiques
WO2010030763A2 (fr) 2008-09-10 2010-03-18 Bind Biosciences, Inc. Fabrication de nanoparticles à rendement élevé
AU2009311667B2 (en) 2008-11-07 2016-04-14 Massachusetts Institute Of Technology Aminoalcohol lipidoids and uses thereof
JP2012512175A (ja) 2008-12-15 2012-05-31 バインド バイオサイエンシズ インコーポレイテッド 治療薬を徐放するための長時間循環性ナノ粒子
WO2010080724A1 (fr) 2009-01-12 2010-07-15 Merck Sharp & Dohme Corp. Nanoparticules lipidiques inédites et composants inédits utilisables pour l'administration d'acides nucléiques
WO2010087791A1 (fr) 2009-01-27 2010-08-05 Utc Power Corporation Réacteur de conversion à la vapeur d'eau intégré, refroidi de manière distributive et atomiseur
US8691211B2 (en) * 2009-03-10 2014-04-08 Puget Sound Blood Center Suppression of immune response to factor VIII in hemophilia A patients
WO2010108108A2 (fr) 2009-03-20 2010-09-23 Egen, Inc. Dérivés de polyamine
KR20230098713A (ko) 2009-06-10 2023-07-04 알닐람 파마슈티칼스 인코포레이티드 향상된 지질 조성물
WO2011000106A1 (fr) 2009-07-01 2011-01-06 Protiva Biotherapeutics, Inc. Lipides cationiques et procédés améliorés pour l'administration d'agents thérapeutiques
CA2767127A1 (fr) 2009-07-01 2011-01-06 Protiva Biotherapeutics, Inc. Formulations lipidiques inedites permettant l'administration d'agents therapeutiques en direction de tumeurs solides
ES2579936T3 (es) 2009-08-20 2016-08-17 Sirna Therapeutics, Inc. Nuevos lípidos catiónicos con diversos grupos de cabeza para el suministro oligonucleotídico
EP2485770A4 (fr) 2009-10-08 2013-04-10 Merck Sharp & Dohme Nouveaux lipides cationiques à chaînes lipidiques courtes pour une administration d'oligonucléotides
JP5823405B2 (ja) 2009-11-04 2015-11-25 ザ ユニバーシティ オブ ブリティッシュ コロンビア 核酸含有脂質粒子および関連方法
WO2011062965A2 (fr) 2009-11-18 2011-05-26 University Of Washington Through Its Center For Commercialization Monomères de ciblage et polymère ayant des blocs de ciblage
WO2011069529A1 (fr) 2009-12-09 2011-06-16 Curevac Gmbh Solution contenant du mannose pour la lyophilisation, la transfection et/ou l'injection d'acides nucléiques
JP5965844B2 (ja) 2009-12-15 2016-08-10 バインド セラピューティックス インコーポレイテッド 高いガラス転移温度または高分子量のコポリマーを有する治療用ポリマーナノ粒子組成物
WO2011084521A2 (fr) 2009-12-15 2011-07-14 Bind Biosciences, Inc. Nanoparticules polymères thérapeutiques comportant de l'épothilone et leurs procédés de fabrication et d'utilisation
WO2011084518A2 (fr) 2009-12-15 2011-07-14 Bind Biosciences, Inc. Nanoparticules polymères thérapeutiques comprenant de corticostéroïdes, et procédés pour les fabriquer et les utiliser
US20130116419A1 (en) 2010-01-22 2013-05-09 Daniel Zewge Post-synthetic chemical modification of rna at the 2'-position of the ribose ring via "click" chemistry
US20130231287A1 (en) 2010-02-25 2013-09-05 Parimala Nacharaju Pegylated albumin polymers and uses thereof
EP2558074B1 (fr) 2010-04-08 2018-06-06 The Trustees of Princeton University Préparation de nanoparticules de lipide
US20110250264A1 (en) 2010-04-09 2011-10-13 Pacira Pharmaceuticals, Inc. Method for formulating large diameter synthetic membrane vesicles
US20110262491A1 (en) 2010-04-12 2011-10-27 Selecta Biosciences, Inc. Emulsions and methods of making nanocarriers
US9254327B2 (en) 2010-05-10 2016-02-09 Alnylam Pharmaceuticals, Inc. Methods and compositions for delivery of active agents
EP2569276B1 (fr) 2010-05-12 2021-02-24 Arbutus Biopharma Corporation Nouveaux lipides cationiques et procédés d'utilisation de ceux-ci
WO2011149733A2 (fr) 2010-05-24 2011-12-01 Merck Sharp & Dohme Corp. Nouveaux lipides cationiques alcools aminés pour l'administration d'oligonucléotides
DK2575767T3 (en) 2010-06-04 2017-03-13 Sirna Therapeutics Inc HOWEVER UNKNOWN LOW MOLECULAR CATIONIC LIPIDS TO PROCESS OIGONUCLEOTIDES
RU2556800C2 (ru) 2010-06-14 2015-07-20 Ф.Хоффманн-Ля Рош Аг Пептиды, проникающие в клетки, и их применения
WO2011163483A2 (fr) 2010-06-25 2011-12-29 Massachusetts Institute Of Technology Polymères pour des biomatériaux et des agents thérapeutiques
BR112013000392B8 (pt) 2010-07-06 2022-10-04 Novartis Ag Composição farmacêutica contendo partícula de distribuição semelhante a vírion para moléculas de rna autorreplicantes e seu uso
MX343410B (es) 2010-07-06 2016-11-04 Novartis Ag * Emulsiones cationicas de agua en aceite.
ES2557382T3 (es) 2010-07-06 2016-01-25 Glaxosmithkline Biologicals Sa Liposomas con lípidos que tienen un valor de pKa ventajoso para el suministro de ARN
US20130211249A1 (en) 2010-07-22 2013-08-15 The Johns Hopkins University Drug eluting hydrogels for catheter delivery
US8968746B2 (en) 2010-07-30 2015-03-03 Curevac Gmbh Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation
WO2012021516A2 (fr) 2010-08-09 2012-02-16 The Trustees Of The University Of Pennsylvania Structures hybrides nanoparticulaires-oligonucléotidiques et leurs méthodes d'utilisation
US20130195799A1 (en) 2010-08-19 2013-08-01 Peg Biosciences, Inc. Synergistic biomolecule-polymer conjugates
DK4066855T3 (da) 2010-08-31 2023-02-20 Glaxosmithkline Biologicals Sa Pegylerede liposomer til forsyning af RNA, der koder for immunogen
JP2013538569A (ja) 2010-08-31 2013-10-17 ノバルティス アーゲー 免疫原をコードするrnaの送達のための小さなリポソーム
EP3542789A3 (fr) 2010-08-31 2020-01-01 GlaxoSmithKline Biologicals SA Lipides adaptés pour une administration liposomale d'arn codant pour une protéine
WO2012039979A2 (fr) 2010-09-10 2012-03-29 The Johns Hopkins University Diffusion rapide de grosses nanoparticules polymères dans le cerveau de mammifères
US8466122B2 (en) 2010-09-17 2013-06-18 Protiva Biotherapeutics, Inc. Trialkyl cationic lipids and methods of use thereof
BR112013004585B1 (pt) 2010-09-20 2021-09-08 Merck Sharp & Dohme Corp Lipídeo catiônico, composição de lnp, e, uso de um lipídeo catiônico
CA2811601A1 (fr) 2010-09-24 2012-03-29 Mallinckrodt Llc Conjugues d'aptameres pour ciblage de nanovecteurs therapeutiques et/ou diagnostiques
CN103260611A (zh) 2010-09-30 2013-08-21 默沙东公司 用于寡核苷酸递送的低分子量阳离子脂质
CA2813024A1 (fr) 2010-10-21 2012-04-26 Merck Sharp & Dohme Corp. Nouveaux lipides cationiques a faible poids moleculaire destines a une administration d'oligonucleotides
US20150056300A1 (en) 2010-10-22 2015-02-26 Bind Therapeutics, Inc. Therapeutic nanoparticles with high molecular weight copolymers
WO2012061259A2 (fr) 2010-11-05 2012-05-10 Merck Sharp & Dohme Corp. Amine cyclique inédite de faible masse moléculaire contenant des lipides cationiques en vue de l'administration d'oligonucléotides
DK3202760T3 (da) 2011-01-11 2019-11-25 Alnylam Pharmaceuticals Inc Pegylerede lipider og deres anvendelse til lægemiddelfremføring
US20140066363A1 (en) 2011-02-07 2014-03-06 Arun K. Bhunia Carbohydrate nanoparticles for prolonged efficacy of antimicrobial peptide
EP2489371A1 (fr) 2011-02-18 2012-08-22 Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria Support peptidique pour l'administration de médicaments
US8846850B2 (en) 2011-02-22 2014-09-30 Rutgers, The State University Of New Jersey Amphiphilic macromolecules for nucleic acid delivery
CA2831613A1 (fr) 2011-03-31 2012-10-04 Moderna Therapeutics, Inc. Administration et formulation d'acides nucleiques genetiquement modifies
US8691750B2 (en) 2011-05-17 2014-04-08 Axolabs Gmbh Lipids and compositions for intracellular delivery of biologically active compounds
AU2012267531B2 (en) 2011-06-08 2017-06-22 Translate Bio, Inc. Lipid nanoparticle compositions and methods for mRNA delivery
JP6022557B2 (ja) 2011-06-08 2016-11-09 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド 切断可能な脂質
US9126966B2 (en) 2011-08-31 2015-09-08 Protiva Biotherapeutics, Inc. Cationic lipids and methods of use thereof
CA2845845A1 (fr) 2011-08-31 2013-03-07 Mallinckrodt Llc Modification de nanoparticules de peg avec des h-phosphonates
WO2013039857A1 (fr) 2011-09-12 2013-03-21 modeRNA Therapeutics Acides nucléiques modifiés et leurs procédés d'utilisation
EP3492109B1 (fr) 2011-10-03 2020-03-04 ModernaTX, Inc. Nucléosides, nucléotides et acides nucléiques modifiés et leurs utilisations
US20150037428A1 (en) 2011-11-29 2015-02-05 The University Of North Carolina At Chapel Hill Geometrically engineered particles and methods for modulating macrophage or immune responses
US20140308304A1 (en) 2011-12-07 2014-10-16 Alnylam Pharmaceuticals, Inc. Lipids for the delivery of active agents
CA3165769A1 (fr) 2011-12-07 2013-06-13 Alnylam Pharmaceuticals, Inc. Lipides biodegradables pour l'administration d'agents actifs
CA2856737C (fr) 2011-12-07 2023-09-26 Alnylam Pharmaceuticals, Inc. Lipides biodegradables ramifies a terminaisons alkyle et cycloalkyle destines a l'administration d'agents actifs
EP2787977A4 (fr) 2011-12-09 2015-05-06 Univ California Encapsulation liposomale de médicaments
WO2013106072A1 (fr) 2012-01-10 2013-07-18 Sorbent Therapeutics, Inc. Compositions comprenant des polymères réticulés de liaison à des cations et utilisations associées
WO2013106086A1 (fr) 2012-01-10 2013-07-18 Sorbent Therapeutics, Inc. Compositions comprenant des polymères réticulés de liaison à des cations et utilisations associées
WO2013106073A1 (fr) 2012-01-10 2013-07-18 Sorbent Therapeutics, Inc. Compositions comprenant des polymères réticulés de liaison à des cations et utilisations associées
WO2013105101A1 (fr) 2012-01-13 2013-07-18 Department Of Biotechnology Nanoparticules lipidiques solides encapsulant un médicament hydrophile/amphiphile et leur procédé de préparation
CA2863632C (fr) 2012-01-19 2017-07-11 The Johns Hopkins University Formulations de nanoparticules presentant une penetration amelioree dans les muqueuses
WO2013116126A1 (fr) 2012-02-01 2013-08-08 Merck Sharp & Dohme Corp. Nouveaux lipides cationiques biodégradables de faible masse moléculaire pour la délivrance d'oligonucléotides
WO2013123298A1 (fr) 2012-02-17 2013-08-22 University Of Georgia Research Foundation, Inc. Nanoparticules de trafic mitochondrial d'agents
CN104394853B (zh) 2012-02-19 2017-10-10 纳维基因股份有限公司 多孔性纳米结构在递送中的用途
WO2013124867A1 (fr) 2012-02-21 2013-08-29 Amrita Vishwa Vidyapeetham University Polymer - polymer or polymer - protein core - shell nano medicine loaded with multiple drug molecules
AU2013222179B2 (en) 2012-02-24 2017-08-24 Arbutus Biopharma Corporat ion Trialkyl cationic lipids and methods of use thereof
WO2013151664A1 (fr) 2012-04-02 2013-10-10 modeRNA Therapeutics Polynucléotides modifiés pour la production de protéines
CA2868391A1 (fr) 2012-04-02 2013-10-10 Stephane Bancel Polynucleotides comprenant du n1-methyl-pseudouracils et methodes pour les preparer
US20140275229A1 (en) * 2012-04-02 2014-09-18 Moderna Therapeutics, Inc. Modified polynucleotides encoding udp glucuronosyltransferase 1 family, polypeptide a1
WO2014028429A2 (fr) 2012-08-14 2014-02-20 Moderna Therapeutics, Inc. Enzymes et polymérases destinées à la synthèse d'arn
EP2931319B1 (fr) 2012-12-13 2019-08-21 ModernaTX, Inc. Molécules d'acide nucléique modifiées et leurs utilisations
US20160022840A1 (en) 2013-03-09 2016-01-28 Moderna Therapeutics, Inc. Heterologous untranslated regions for mrna
US20160151284A1 (en) 2013-07-23 2016-06-02 Protiva Biotherapeutics, Inc. Compositions and methods for delivering messenger rna
SG11201602503TA (en) 2013-10-03 2016-04-28 Moderna Therapeutics Inc Polynucleotides encoding low density lipoprotein receptor
EP3556353A3 (fr) 2014-02-25 2020-03-18 Merck Sharp & Dohme Corp. Adjuvants de vaccins à nanoparticules lipidiques et systèmes d'administration d'antigènes
SI3766916T1 (sl) 2014-06-25 2023-01-31 Acuitas Therapeutics Inc. Formulacije novih lipidov in lipidnih nanodelcev za dostavo nukleinskih kislin
RS63030B1 (sr) * 2015-09-17 2022-04-29 Modernatx Inc Jedinjenja i kompozicije za intracelularno isporučivanje terapeutskih sredstava

Also Published As

Publication number Publication date
WO2018232006A1 (fr) 2018-12-20
EP3638292A1 (fr) 2020-04-22
US20200268666A1 (en) 2020-08-27

Similar Documents

Publication Publication Date Title
MA45051A (fr) Polynucléotides codant la relaxine
MA50014A (fr) Modulateurs de k-ras
MA43568A (fr) Polynucléotides codant pour la méthylmalonyl-coa mutase
ZA201904140B (en) Hybrid-srs combination signaling
CL2017002628S1 (es) Máquina de afeitar
CL2017002779S1 (es) Máquina de afeitar
DK3680364T3 (da) Elektrolyseindretning
DK3583268T3 (da) Signaleringssystem
IL267806A (en) Multimeric oligonucleotides with reduced renal clearance
CL2018000650S1 (es) Sujetador.
DK3603249T3 (da) Ressourceallokeringssignalering
IL283671A (en) Backwash system
DE112018000104A5 (de) Ablage
DK3457010T3 (da) Fluid-omskifter
ES2981739T3 (es) Prensa de carrera ajustable, con bloque de corredera
MA49395A (fr) Polynucléotides codant pour le facteur viii de coagulation
FI11882U1 (fi) Sähkökytkin
FR3032494B1 (fr) Aube de soufflante
DK3675844T3 (da) Bmp-mimetik
DK3346031T3 (da) Multifunktionel polymerkomposittråd
ES1187312Y (es) Dispositivo de senalizacion
GB201706657D0 (en) Polymers
DE102016007931A8 (de) Biomaterial
KR20180084900A (ko) 전기적으로 결합 가능한 조립 블록
DK3503688T3 (da) Lyskaster